Suresh Poda

Suresh Poda, Ph.D. is an accomplished leader in the field of cell and gene therapy, currently serving as President at Laurus Labs Limited, where the focus is on Cell and Gene Therapy & Antibody Drug Conjugates. With extensive experience, Suresh holds positions on the Scientific Advisory Board of 1910 Genetics and as a Scientific Advisor at the Wyss Institute at Harvard University. Previous roles include Vice President at Encoded Therapeutics Inc., Head of Biology at Eisai Center for Genetics Guided Dementia Discovery, and Senior Director at Denali Therapeutics. Suresh's early career involved significant contributions at Lundbeck and AstraZeneca, emphasizing neuroscience and pharmacology. Educational qualifications include a Post Doctoral Fellowship from the University of Michigan and a Ph.D. from Université de Montréal, complemented by executive education at MIT Sloan School of Management.